Cytokeratin 13 anticorps

N° du produit ABIN335223

Détail du produit anti-Cytokeratin 13 anticorps

Antigène: Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))

Reactivité: Humain, Rat, Souris

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Cytokeratin 13 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), Immunohistochemistry (Frozen Sections) (IHC (fro))

Specificité: Mab 2D7 specifically recognizes keratin K13 (54 kD polypeptide, formerly designated cytokeratin 13) present in non-cornifying squamous epithelia and in transitional epithelium of the bladder. Epidermal cell culture studies have shown that keratin K13 expression is involved in either the number or the strength of desmosomal contacts between suprabasal cells of stratified squamous epithelia. Reacts with Human, most mammals incl. mouse, rat, rabbit.

Purification: Supernatant

Immunogène: Keratin preparation from human esophagus.

Clone: 2D7

Isotype: IgG2b

Information d'application

Indications d'application: Immunofluorescence. Immunohistochemistry on frozen sections: 1:5 - 1:10. Immunoblotting. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Stock: 4 °C

Références pour anticorps anti-Cytokeratin 13 (ABIN335223)

van Dorst, van Muijen, Litvinov, Fleuren: "The limited difference between keratin patterns of squamous cell carcinomas and adenocarcinomas is explicable by both cell lineage and state of differentiation of tumour cells." dans: Journal of clinical pathology, Vol. 51, Issue 9, pp. 679-84, (1999) (PubMed).

Van Niekerk, Ramaekers, Hanselaar, Aldeweireldt, Poels: "Changes in expression of differentiation markers between normal ovarian cells and derived tumors." dans: The American journal of pathology, Vol. 142, Issue 1, pp. 157-77, (1993) (PubMed).

Bauwens, De Groot, Ramaekers, Veldman, Huizing: "Expression of intermediate filament proteins in the adult human vestibular labyrinth." dans: The Annals of otology, rhinology, and laryngology, Vol. 101, Issue 6, pp. 479-86, (1992) (PubMed).

Smedts, Ramaekers, Troyanovsky, Pruszczynski, Link, Lane, Leigh, Schijf, Vooijs: "Keratin expression in cervical cancer." dans: The American journal of pathology, Vol. 141, Issue 2, pp. 497-511, (1992) (PubMed).

van Niekerk, Boerman, Ramaekers, Poels: "Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas." dans: The American journal of pathology, Vol. 138, Issue 2, pp. 455-63, (1991) (PubMed).

Smedts, Ramaekers, Robben, Pruszczynski, van Muijen, Lane, Leigh, Vooijs: "Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia." dans: The American journal of pathology, Vol. 136, Issue 3, pp. 657-68, (1990) (PubMed).

Weikel, Wagner, Moll: "Characterization of subcolumnar reserve cells and other epithelia of human uterine cervix. Demonstration of diverse cytokeratin polypeptides in reserve cells." dans: Virchows Archiv. B, Cell pathology including molecular pathology, Vol. 54, Issue 2, pp. 98-110, (1988) (PubMed).

van Muijen, Ruiter, Franke, Achtstätter, Haasnoot, Ponec, Warnaar: "Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13." dans: Experimental cell research, Vol. 162, Issue 1, pp. 97-113, (1986) (PubMed).

Détails sur Cytokeratin 13

Antigène: Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))

Autre désignation: Cytokeratin 13 / Keratin K13 (KRT13 Produits)

Synonymes: anticorps krt13, anticorps CK13, anticorps K13, anticorps Ka13, anticorps Krt-1.13, anticorps Krt1-13, anticorps ck13, anticorps k13, anticorps keratin 24, anticorps keratin 13, anticorps keratin 13, type I S homeolog, anticorps krt24, anticorps KRT13, anticorps Krt13, anticorps krt13.S, anticorps k13

UniProt: P13646